SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: richard davis who wrote (1744)2/15/1997 9:50:00 AM
From: lloyd bashaw   of 4342
 
Rick, Thankyou for the welcome. My research on Paracelsian is that of the online variety. (Thank goodness for the net.) From Edgar, news services, HIV and Cancer threads,and this thread I at least have a feel for Paracelsian's situation,and I must say I like the prospects.

Yes, my friend is an equities analyst for a major firm. He also runs a fund for a state employee retirement system. He has purchased Paracelsian for his personal account. His fund is not of the "growth" type.

Yes, I am sincerely anticipating an interesting ride. I truly believe that 4 dollars per share is imminent and that in the future Paracelsian has a bonafide chance to produce some astonishing revenues precipitating a meteoric rise coupled with the obligatory stock splits.

Yes, I have bought the stock. Fundamentally I love the concept of this company. This is the time to purchase PRLN. The company is poised for explosive growth. If by chance they do not succeed the downside is minimal here.

I use interquote for rt ticks. I logged off at 4:01pm and the volume was 107,400. Checking back later I was a bit surprised to see 32,000 shares (vol 139,400) as the final tally. After-hours trading is available through instinet for the aftermarkets. Institutions and individuals may trade in the aftermarket.

Best Wishes, Lloyd
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext